Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography

Publication Date

2018

Journal Title

Clin Liver Dis

Abstract

© 2017 The incidence and prevalence of nonalcoholic fatty liver disease (NAFLD) are increasing and identification of people at risk of disease progression is extremely important. The current gold standard for diagnosing NAFLD/nonalcoholic steatohepatitis (NASH) is by liver biopsy, but it has several limitations. Noninvasive tests via biomarkers and transient elastography to assess NAFLD/NASH are being used in clinical practice. The most validated diagnostic panels include the NAFLD fibrosis score, FIB-4 (Fibrosis-4), and FibroMeter. Transient elastography is very useful in evaluating advanced fibrosis and cirrhosis.

Volume Number

22

Issue Number

1

Pages

73 - 92

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Hepatology

PMID

29128062

DOI

10.1016/j.cld.2017.08.004

For the public and Northwell Health campuses

Share

COinS